| Product Code: ETC7909768 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia saw significant import shipments of drug-device combination products primarily from Lithuania, Netherlands, Switzerland, Poland, and Germany. The market remained competitive with low concentration, as indicated by the Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 was robust at 8.6%, reflecting a growing market demand. Furthermore, the growth rate from 2023 to 2024 stood at 7.03%, indicating continued momentum in the importation of drug-device combination products into Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Drug-Device Combination Products Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Drug-Device Combination Products Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Latvia Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Latvia Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Latvia Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Latvia Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2022 & 2032F |
4 Latvia Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Latvia, driving the demand for more effective treatment options. |
4.2.2 Growing focus on personalized medicine and targeted therapies, leading to the development and adoption of drug-device combination products. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for drug-device combination products, increasing time to market and costs. |
4.3.2 Limited awareness and education among healthcare professionals and patients about the benefits and proper usage of these products. |
5 Latvia Drug-Device Combination Products Market Trends |
6 Latvia Drug-Device Combination Products Market, By Types |
6.1 Latvia Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Latvia Drug-Device Combination Products Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Latvia Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2022 - 2032F |
6.1.4 Latvia Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2022 - 2032F |
6.1.5 Latvia Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2022 - 2032F |
6.1.6 Latvia Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2022 - 2032F |
6.1.7 Latvia Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2022 - 2032F |
6.1.8 Latvia Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2022 - 2032F |
6.1.9 Latvia Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.1.10 Latvia Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.2 Latvia Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2022 - 2032F |
6.2.3 Latvia Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.2.4 Latvia Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2022 - 2032F |
6.2.5 Latvia Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2022 - 2032F |
6.2.6 Latvia Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2022 - 2032F |
6.2.7 Latvia Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.3 Latvia Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Latvia Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2022 - 2032F |
6.3.3 Latvia Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2022 - 2032F |
6.3.4 Latvia Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2022 - 2032F |
6.3.5 Latvia Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
7 Latvia Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Latvia Drug-Device Combination Products Market Export to Major Countries |
7.2 Latvia Drug-Device Combination Products Market Imports from Major Countries |
8 Latvia Drug-Device Combination Products Market Key Performance Indicators |
8.1 Percentage of healthcare professionals trained on the use of drug-device combination products. |
8.2 Number of clinical trials and research studies conducted on new drug-device combination products in Latvia. |
8.3 Rate of adoption of drug-device combination products compared to traditional treatment options in key therapeutic areas. |
9 Latvia Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Latvia Drug-Device Combination Products Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Latvia Drug-Device Combination Products Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Latvia Drug-Device Combination Products Market Opportunity Assessment, By End user, 2022 & 2032F |
10 Latvia Drug-Device Combination Products Market - Competitive Landscape |
10.1 Latvia Drug-Device Combination Products Market Revenue Share, By Companies, 2025 |
10.2 Latvia Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here